health_en

Vaccines alone aren’t enough to combat AMR, claims new WHO report

The Global Hygiene Council (GHC) calls for the use of hygiene practices, such as handwashing, alongside vaccinations to prevent the spread of infectious diseases and reduce the impact of antimicrobial resistance (AMR). A recent report published by the World Health Organization (WHO) identified vaccines as “highly effective tools in combating AMR”. Despite their efficacy, the financial risks […]

thaipr.net

25 ก.ค. 65

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 – Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical…

thaipr.net

22 ก.ค. 65

Congratulations! Kexing Biopharm (688136.SH) was awarded by the” Annual Top 20 Chinese Biopharmaceutical Entreprises”

On 12 July 2022, Menet held the award ceremony of the “Annual Top 100 China’s Pharmaceutical Entreprises in 2021”, in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the top companies in China’s pharmaceutical industry. With the solid R&D and production strength and the strong […]

thaipr.net

22 ก.ค. 65

DarwinHealth Publishes Results of Novel, Viral Checkpoint-based Technology for Predicting Drugs that Inhibit SARS-CoV-2 Replication: Global Collaboration Highlights Generalizability of Reported ViroTreat Model for Host Cell-Directed Antiviral Drug Discovery, the Role of Master Regulator Proteins, and Application to other Viral Pathogens and Pandemic Response

DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the July 19, 2022 online publication in Communications Biology (a Nature Portfolio peer-reviewed journal) of a foundational paper focused on new approaches to antiviral drug discovery, “A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral…

thaipr.net

19 ก.ค. 65

Zymo Research’s DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg, Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolates. This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking methods to safely collect and transport samples […]

thaipr.net

15 ก.ค. 65
1 … 65 66 67 68 69 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.